HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effect of serofendic acid, administered intravenously, on cerebral ischemia-reperfusion injury in rats.

Abstract
Serofendic acid is a low-molecular-weight compound extracted from fetal calf serum. We previously reported that intracerebroventricular administration of serofendic acid prevents cerebral ischemia-reperfusion injury. However, the effect of peripheral administration of serofendic acid on cerebral ischemia-reperfusion injury has not been examined. In the present study, we investigated the effect of intravenous administration of serofendic acid against cerebral ischemia-reperfusion injury using transient middle cerebral artery occlusion model rats. Serofendic acid (10mg/kg) administrated three times, including 30min before the onset of ischemia, just after the onset of ischemia and just before reperfusion reduced the infarct volume and improved the neurological dysfunction induced by ischemia-reperfusion without affecting regional cerebral blood flow or physiological parameters. However, there were no protective effects when serofendic acid (30mg/kg) was only administered once at 30min before the onset of ischemia, just after the onset of ischemia, or just before reperfusion. Our results reveal the importance of maintaining the blood concentration of serofendic acid for preventing cerebral ischemia-reperfusion injury.
AuthorsTadaaki Ioroi, Kazuya Taguchi, Yasuhiko Izumi, Yuki Takada-Takatori, Akinori Akaike, Toshiaki Kume
JournalBrain research (Brain Res) Vol. 1532 Pg. 99-105 (Sep 26 2013) ISSN: 1872-6240 [Electronic] Netherlands
PMID23954678 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 The Authors. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Diterpenes
  • Neuroprotective Agents
  • serofendic acid
Topics
  • Administration, Intravenous
  • Animals
  • Brain (pathology)
  • Brain Ischemia (drug therapy)
  • Diterpenes (administration & dosage, therapeutic use)
  • Male
  • Neuroprotective Agents (administration & dosage, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: